UBS Group downgraded NMI from buy to neutral with a $39 target.

UBS Group downgraded NMI (NASDAQ:NMIH) from a buy rating to a neutral rating in a report published on Wednesday, setting a $39.00 target price. Analysts at JPMorgan Chase & Co. raised their price objective from $35.00 to $36.00, while Truist Financial increased their target from $36.00 to $37.00.

May 26, 2024
3 Articles